243 related articles for article (PubMed ID: 17003289)
21. New insights concerning the glucose-dependent insulin secretagogue action of glucagon-like peptide-1 in pancreatic beta-cells.
Holz GG
Horm Metab Res; 2004; 36(11-12):787-94. PubMed ID: 15655710
[TBL] [Abstract][Full Text] [Related]
22. GLP-1 stimulates insulin secretion by PKC-dependent TRPM4 and TRPM5 activation.
Shigeto M; Ramracheya R; Tarasov AI; Cha CY; Chibalina MV; Hastoy B; Philippaert K; Reinbothe T; Rorsman N; Salehi A; Sones WR; Vergari E; Weston C; Gorelik J; Katsura M; Nikolaev VO; Vennekens R; Zaccolo M; Galione A; Johnson PR; Kaku K; Ladds G; Rorsman P
J Clin Invest; 2015 Dec; 125(12):4714-28. PubMed ID: 26571400
[TBL] [Abstract][Full Text] [Related]
23. cAMP-activated protein kinase-independent potentiation of insulin secretion by cAMP is impaired in SUR1 null islets.
Nakazaki M; Crane A; Hu M; Seghers V; Ullrich S; Aguilar-Bryan L; Bryan J
Diabetes; 2002 Dec; 51(12):3440-9. PubMed ID: 12453898
[TBL] [Abstract][Full Text] [Related]
24. Insulin exocytosis in Goto-Kakizaki rat beta-cells subjected to long-term glinide or sulfonylurea treatment.
Kawai J; Ohara-Imaizumi M; Nakamichi Y; Okamura T; Akimoto Y; Matsushima S; Aoyagi K; Kawakami H; Watanabe T; Watada H; Kawamori R; Nagamatsu S
Biochem J; 2008 May; 412(1):93-101. PubMed ID: 18254725
[TBL] [Abstract][Full Text] [Related]
25. Effect of insulinotropic agent nateglinide on Kv and Ca(2+) channels in pancreatic beta-cell.
Hu S; Wang S
Eur J Pharmacol; 2001 Sep; 427(2):97-104. PubMed ID: 11557260
[TBL] [Abstract][Full Text] [Related]
26. Sulphonylurea receptor-1, sulphonylureas and amplification of insulin secretion by Epac activation in β cells.
Nenquin M; Henquin JC
Diabetes Obes Metab; 2016 Jul; 18(7):698-701. PubMed ID: 26584950
[TBL] [Abstract][Full Text] [Related]
27. [Progress in therapy for diabetes mellitus--insulin-secretion inducing oral hypoglycemic agents].
Nagashima K; Inagaki N
Nihon Naika Gakkai Zasshi; 2009 Apr; 98(4):737-41. PubMed ID: 19472523
[No Abstract] [Full Text] [Related]
28. Glucose regulation of insulin secretion independent of the opening or closure of adenosine triphosphate-sensitive K+ channels in beta cells.
Sato Y; Anello M; Henquin JC
Endocrinology; 1999 May; 140(5):2252-7. PubMed ID: 10218978
[TBL] [Abstract][Full Text] [Related]
29. Stimulation of pancreatic beta-cell replication by incretins involves transcriptional induction of cyclin D1 via multiple signalling pathways.
Friedrichsen BN; Neubauer N; Lee YC; Gram VK; Blume N; Petersen JS; Nielsen JH; Møldrup A
J Endocrinol; 2006 Mar; 188(3):481-92. PubMed ID: 16522728
[TBL] [Abstract][Full Text] [Related]
30. Effects of D-phenylalanine-derivative hypoglycemic agent A-4166 on pancreatic alpha- and beta-cells: comparative study with glibenclamide.
Hirose H; Maruyama H; Seto Y; Ito K; Fujita T; Dan K; Kanda N; Saruta T; Kato R
Pharmacology; 1995 Mar; 50(3):175-81. PubMed ID: 7746834
[TBL] [Abstract][Full Text] [Related]
31. Glinide, but not sulfonylurea, can evoke insulin exocytosis by repetitive stimulation: imaging analysis of insulin exocytosis by secretagogue-induced repetitive stimulations.
Aoyagi K; Ohara-Imaizumi M; Nishiwaki C; Nakamichi Y; Nagamatsu S
Exp Diabetes Res; 2009; 2009():278762. PubMed ID: 20069052
[TBL] [Abstract][Full Text] [Related]
32. Nateglinide, a D-phenylalanine derivative lacking either a sulfonylurea or benzamido moiety, specifically inhibits pancreatic beta-cell-type K(ATP) channels.
Chachin M; Yamada M; Fujita A; Matsuoka T; Matsushita K; Kurachi Y
J Pharmacol Exp Ther; 2003 Mar; 304(3):1025-32. PubMed ID: 12604678
[TBL] [Abstract][Full Text] [Related]
33. Insulinotropic action of meglitinide analogues: modulation by an activator of ATP-sensitive K+ channels and high extracellular K+ concentrations.
Malaisse WJ
Pharmacol Res; 1995 Sep; 32(3):111-4. PubMed ID: 8745339
[TBL] [Abstract][Full Text] [Related]
34. Insulin stimulus-secretion coupling is triggered by a novel thiazolidinedione/sulfonylurea hybrid in rat pancreatic islets.
Mendes CP; Postal BG; Oliveira GTC; Castro AJG; Frederico MJS; Moraes ALL; Neuenfeldt PD; Nunes RJ; Menegaz D; Silva FRMB
J Cell Physiol; 2018 Jan; 234(1):509-520. PubMed ID: 29968920
[TBL] [Abstract][Full Text] [Related]
35. Effectiveness of nateglinide on in vitro insulin secretion from rat pancreatic islets desensitized to sulfonylureas.
Hu S; Wang S; Dunning BE
Int J Exp Diabetes Res; 2001; 2(1):73-9. PubMed ID: 12369729
[TBL] [Abstract][Full Text] [Related]
36. Insulin secretion from isolated rat islets induced by the novel hypoglycemic agent A-4166, a derivative of D-phenylalanine.
Tsukuda K; Sakurada M; Niki I; Oka Y; Kikuchi M
Horm Metab Res; 1998 Jan; 30(1):42-9. PubMed ID: 9503038
[TBL] [Abstract][Full Text] [Related]
37. Low, but physiological, concentration of GLP-1 stimulates insulin secretion independent of the cAMP-dependent protein kinase pathway.
Shigeto M; Katsura M; Matsuda M; Ohkuma S; Kaku K
J Pharmacol Sci; 2008 Nov; 108(3):274-9. PubMed ID: 18987435
[TBL] [Abstract][Full Text] [Related]
38. Additive hypoglycaemic effect of nateglinide and exogenous glucagon-like peptide-1 in type 2 diabetes.
Bell PM; Cuthbertson J; Patterson S; O'Harte FP
Diabetes Res Clin Pract; 2011 Mar; 91(3):e68-70. PubMed ID: 21194775
[TBL] [Abstract][Full Text] [Related]
39. Sulfonylurea and glinide reduce insulin content, functional expression of K(ATP) channels, and accelerate apoptotic beta-cell death in the chronic phase.
Takahashi A; Nagashima K; Hamasaki A; Kuwamura N; Kawasaki Y; Ikeda H; Yamada Y; Inagaki N; Seino Y
Diabetes Res Clin Pract; 2007 Sep; 77(3):343-50. PubMed ID: 17316868
[TBL] [Abstract][Full Text] [Related]
40. Glucagon-like peptide 1-potentiated insulin secretion and proliferation of pancreatic β-cells.
Ma X; Guan Y; Hua X
J Diabetes; 2014 Sep; 6(5):394-402. PubMed ID: 24725840
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
